SCHEMBL5773905

SCHEMBL5773905

O=C(O)CCC(=O)C1CSCCC1=O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.33
LMNA P02545 1/20 0.31
ALKBH5 Q6P6C2 1/20 0.31
SUCNR1 Q9BXA5 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676041 0.77 MCL1 (0.32)
SCHEMBL5770917 0.73 MCL1 (0.43) FOLH1LMNAALKBH5SUCNR1EGLN1
SCHEMBL2718691 0.71 MCL1 (0.50) FOLH1LMNA
SCHEMBL5773706 0.70 MCL1 (0.49) LMNA
SCHEMBL2449128 0.69 POLB (0.43) LMNA
SCHEMBL2904103 0.68 KMT2A (0.36)
SCHEMBL4947382 0.66 MAPT (0.34) LMNA
SCHEMBL9930248 0.62
SCHEMBL10423031 0.62 FOLH1 (0.42) FOLH1LMNA
Succinic Acid SCHEMBL9421166 0.61 LMNA (0.43) FOLH1LMNAALKBH5SUCNR1EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed